These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 7506194)

  • 21. The in vivo pharmacological profile of CS-747, a novel antiplatelet agent with platelet ADP receptor antagonist properties.
    Sugidachi A; Asai F; Ogawa T; Inoue T; Koike H
    Br J Pharmacol; 2000 Apr; 129(7):1439-46. PubMed ID: 10742300
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of platelet aggregation in vitro and ex vivo by the new thromboxane antagonist (3R)-3-(4-fluorophenylsulfonamido)-1,2,3,4-tetrahydro-9- carbazolepropanoic acid.
    Seuter F; Perzborn E; Rosentreter U; Böshagen H; Fiedler VB
    Arzneimittelforschung; 1989 Dec; 39(12):1525-7. PubMed ID: 2624599
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Changes of rabbit platelet function on simultaneous administration of ticlopidine hydrochloride and OKY-046.
    Kosugi T; Nakamura M; Saitoh S; Kinjoh K
    Int J Tissue React; 1991; 13(3):123-9. PubMed ID: 1960013
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of the new antiplatelet agent 2-methyl-3-(1,4,5,6-tetrahydronicotinoyl)pyrazolo[1,5-a]pyridine on platelet aggregation and thrombosis in experimental animals.
    Momo K; Someya K; Tachiiri T; Mitsuoka Y; Nakamura K; Imai S; Ino T; Ohkubo H
    Arzneimittelforschung; 1992 Jan; 42(1):32-9. PubMed ID: 1586377
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis, platelet anti-aggregating activity and anti-inflammatory activity of a series of beta-aminoxypropionic acids.
    Macchia M; Orlandini E; Rossello A; Bertini S; Soldani G; Baldacci M; Gervasi G
    Farmaco; 1994 Dec; 49(12):767-73. PubMed ID: 7893333
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Repeat oral dosing of prasugrel, a novel P2Y12 receptor inhibitor, results in cumulative and potent antiplatelet and antithrombotic activity in several animal species.
    Niitsu Y; Sugidachi A; Ogawa T; Jakubowski JA; Hashimoto M; Isobe T; Otsuguro K; Asai F
    Eur J Pharmacol; 2008 Jan; 579(1-3):276-82. PubMed ID: 17996866
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of in vitro platelet aggregation and its inhibition by three antithrombotic drugs between human and guinea pig.
    Huang ZS; Lee TK
    Proc Natl Sci Counc Repub China B; 1991 Feb; 15(1):8-14. PubMed ID: 1946813
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tepoxalin: a dual cyclooxygenase/5-lipoxygenase inhibitor of arachidonic acid metabolism with potent anti-inflammatory activity and a favorable gastrointestinal profile.
    Argentieri DC; Ritchie DM; Ferro MP; Kirchner T; Wachter MP; Anderson DW; Rosenthale ME; Capetola RJ
    J Pharmacol Exp Ther; 1994 Dec; 271(3):1399-408. PubMed ID: 7996452
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antithrombotic effects of 3-([1:1',2':1"]-3'-terphenyl)propanol in animals.
    Hongou K; Miyamae T; Hashizume H; Oshima K; Ogawa T; Hongou T; Morikawa T; Hagiwara M
    Arzneimittelforschung; 1997 Oct; 47(10):1104-8. PubMed ID: 9368702
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Inhibition of platelet function by L-arginine.L-aspartate salt].
    Wang YY; Wang JY; Fu YL; Wang C; Peng SQ
    Sheng Li Xue Bao; 2001 Aug; 53(4):303-6. PubMed ID: 11930210
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibitory effects of copper-aspirin complex on platelet aggregation.
    Shen ZQ; Chen ZH; Ma GY; Wang DC; Wu WL; Liu WP; Yang YK; Xiong HZ
    Zhongguo Yao Li Xue Bao; 1997 Jul; 18(4):358-62. PubMed ID: 10072923
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 5-substituted 4-isoxazolecarboxamides with platelet antiaggregating and other activities.
    Fossa P; Menozzi G; Schenone P; Filippelli W; Russo S; Lucarelli C; Marmo E
    Farmaco; 1991 Jun; 46(6):789-802. PubMed ID: 1772564
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The antiaggregating and antithrombotic activity of ticlopidine is potentiated by aspirin in the rat.
    Herbert JM; Bernat A; Samama M; Maffrand JP
    Thromb Haemost; 1996 Jul; 76(1):94-8. PubMed ID: 8819259
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibitory effect of tetrahydroberberine on platelet aggregation and thrombosis.
    Xuan B; Wang W; Li DX
    Zhongguo Yao Li Xue Bao; 1994 Mar; 15(2):133-5. PubMed ID: 8010106
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antiplatelet effect of acetylsalicylic acid, metamizole and their combination - in vitro and in vivo comparisons.
    Papp J; Sandor B; Vamos Z; Botor D; Toth A; Rabai M; Kenyeres P; Cseplo P; Juricskay I; Mezosi E; Koller A; Toth K
    Clin Hemorheol Microcirc; 2014; 56(1):1-12. PubMed ID: 23076007
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hydroxychavicol, a novel betel leaf component, inhibits platelet aggregation by suppression of cyclooxygenase, thromboxane production and calcium mobilization.
    Chang MC; Uang BJ; Tsai CY; Wu HL; Lin BR; Lee CS; Chen YJ; Chang CH; Tsai YL; Kao CJ; Jeng JH
    Br J Pharmacol; 2007 Sep; 152(1):73-82. PubMed ID: 17641677
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antianaphylactic and antihistaminic activity of the non-steroidal anti-inflammatory compound nimesulide in guinea-pig.
    Berti F; Rossoni G; Buschi A; Robuschi M; Villa LM
    Arzneimittelforschung; 1990 Sep; 40(9):1011-6. PubMed ID: 1981969
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of Bay U 3405, a novel thromboxane A2/endoperoxide receptor antagonist.
    Perzborn E; Fiedler VB; Seuter F; Stasch JP; Weber H; Sander E; Böshagen H; Rosentreter U
    Stroke; 1990 Dec; 21(12 Suppl):IV143-5. PubMed ID: 2148034
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Benzo[6,7]cyclohepta[1,2-b]pyran derivatives with platelet antiaggregating and other activities.
    Bargagna A; Longobardi M; Mariani E; Schenone P; Cenicola ML; Losasso C; Carnevale M; Marmo E
    Farmaco; 1991 Mar; 46(3):461-75. PubMed ID: 1892503
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Clinical evaluation of platelet antagonists on the ex vivo inhibitory effects of platelet aggregation].
    Sakata T; Kobayashi K; Katayama Y; Takada T; Matsuyama T
    Rinsho Byori; 1991 Mar; 39(3):315-20. PubMed ID: 2051607
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.